Heterogeneity of mitochondrial energy metabolism in classical triphasic Wilms' tumor

Frontiers in Bioscience - Elite

Volumn 3 E, Issue 1, 2011, Pages 187-193

  Feichtinger, Rene G ^a   Neureiter, Daniel ^a   Royer Pokora, Brigitte ^b   Mayr, Johannes A ^a   Zimmermann, Franz A ^a   Jones, Neil ^a   Koegler, Christian ^c   Ratschek, Manfred ^c   Sperl, Wolfgang ^a   Kofler, Barbara ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Blastema; Epithelial Mesenchymal Transition; OXPHOS; Respiratory Chain; Stroma

Indexed keywords

CITRATE SYNTHASE; COMPLEX V; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; OXIDOREDUCTASE; PORIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ARTICLE; BLASTEMA; CELL HETEROGENEITY; CONTROLLED STUDY; COPY NUMBER VARIATION; DOWN REGULATION; ENERGY METABOLISM; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; KIDNEY EPITHELIUM; KIDNEY PARENCHYMA; MITOCHONDRIAL RESPIRATION; NEPHROBLASTOMA; STROMA; TUMOR DIFFERENTIATION; UPREGULATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MITOCHONDRION; PATHOPHYSIOLOGY; PHYSIOLOGY; SPECTROPHOTOMETRY; WESTERN BLOTTING;

BLOTTING, WESTERN; CITRATE (SI)-SYNTHASE; DNA, MITOCHONDRIAL; ENERGY METABOLISM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MITOCHONDRIA; OXIDOREDUCTASES; SPECTROPHOTOMETRY; WILMS TUMOR;

EID: 79957870812     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. O. Warburg: On the origin of cancer cells. Science, 123(3191), 309-14 (1956)
2. P. L. Pedersen: Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res, 22190- 274 (1978)
3. E. Racker and M. Spector: Warburg effect revisited: merger of biochemistry and molecular biology. Science, 213(4505), 303-7 (1981)
4. M. W. Dewhirst, T. W. Secomb, E. T. Ong, R. Hsu and J. F. Gross: Determination of local oxygen consumption rates in tumors. Cancer Res, 54(13), 3333-6 (1994) (Pubitemid 24225942)
5. G. Helmlinger, F. Yuan, M. Dellian and R. K. Jain: Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. N at Med, 3(2), 177-82 (1997) (Pubitemid 27064702)
6. R. A. Gatenby: Application of competition theory to tumour growth: implications for tumour biology and treatment. Eur J Cancer, 32A(4), 722-6 (1996)
7. T. G. Graeber, C. Osmanian, T. Jacks, D. E. Housman, C. J. Koch, S. W. Lowe and A. J. Giaccia: Hypoxiamediated selection of cells with diminished apoptotic potential in solid tumours. Nature, 379(6560), 88-91 (1996) (Pubitemid 26008141)
8. C. V. Dang, B. C. Lewis, C. Dolde, G. Dang and H. Shim: Oncogenes in tumor metabolism, tumorigenesis, and apoptosis. J Bioenerg Biomembr, 29(4), 345-54 (1997) (Pubitemid 27498414)
9. R. C. Osthus, H. Shim, S. Kim, Q. Li, R. Reddy, M. Mukherjee, Y. Xu, D. Wonsey, L. A. Lee and C. V. Dang: Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem, 275(29), 21797-800 (2000) (Pubitemid 30621745)
10. Y. Noguchi, T. Okamoto, D. Marat, T. Yoshikawa, A. Saitoh, C. Doi, K. Fukuzawa, A. Tsuburaya, S. Satoh and T. Ito: Expression of facilitative glucose transporter 1 mRNA in colon cancer was not regulated by k-ras. Cancer Lett, 154(2), 137-42 (2000) (Pubitemid 30259220)
11. H. Dihazi, R. Kessler and K. Eschrich: Glucose-induced stimulation of the Ras-cAMP pathway in yeast leads to multiple phosphorylations and activation of 6- phosphofructo-2-kinase. Biochemistry, 42(20), 6275-82 (2003) (Pubitemid 36605131)
12. L. Dejean, B. Beauvoit, O. Bunoust, B. Guerin and M. Rigoulet: Activation of Ras cascade increases the mitochondrial enzyme content of respiratory competent yeast. Biochem Biophys Res Commun, 293(5), 1383-8 (2002) (Pubitemid 34681030)
13. R. Blum, J. Jacob-Hirsch, N. Amariglio, G. Rechavi and Y. Kloog: Ras inhibition in glioblastoma downregulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. Cancer Res, 65(3), 999-1006 (2005) (Pubitemid 40216462)
14. C. Chen, N. Pore, A. Behrooz, F. Ismail-Beigi and A. Maity: Regulation of glut1 mRNA by hypoxiainducible factor-1. Interaction between H-ras and h ypoxia. J Biol Chem, 276(12), 9519-25 (2001)
15. S. P. Mathupala, C. Heese and P. L. Pedersen: Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J Biol Chem, 272(36), 22776-80 (1997) (Pubitemid 27386097)
16. S. Matoba, J. G. Kang, W. D. Patino, A. Wragg, M. Boehm, O. Gavrilova, P. J. Hurley, F. Bunz and P. M. Hwang: p53 regulates mitochondrial respiration. Science, 312(5780), 1650-3 (2006) (Pubitemid 43902663)
17. M. Kulawiec, V. Ayyasamy and K. K. Singh: p53 regulates mtDNA copy number and mitocheckpoint pathway. J Carcinog, 88 (2009)
18. F. Li, Y. Wang, K. I. Zeller, J. J. Potter, D. R. Wonsey, K. A. O'Donnell, J. W. Kim, J. T. Yustein, L. A. Lee and C. V. Dang: Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol Cell Biol, 25(14), 6225-34 (2005) (Pubitemid 40946570)
19. M. Lopez-Lazaro: The warburg effect: why and how do cancer cells activate glycolysis in the presence of oxygen? Anticancer Agents Med Chem, 8(3), 305-12 (2008) (Pubitemid 351761435)
20. J. A. Mayr, D. Meierhofer, F. Zimmermann, R. Feichtinger, C. Kogler, M. Ratschek, N. Schmeller, W. Sperl and B. Kofler: Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma. Clin Cancer Res, 14(8), 2270-5 (2008) (Pubitemid 351551057)
21. F. A. Zimmermann, J. A. Mayr, D. Neureiter, R. Feichtinger, B. Alinger, N. D. Jones, W. Eder, W. Sperl and B. Kofler: Lack of complex I is associated with oncocytic thyroid tumours. Br J Cancer, 100(9), 1434-7 (2009)
22. R. G. Feichtinger, F. Zimmermann, J. A. Mayr, D. Neureiter, C. Hauser-Kronberger, F. H. Schilling, N. Jones, W. Sperl and B. Kofler: Low aerobic mitochondrial energy metabolism in poorly- or undifferentiated neuroblastoma. BMC Cancer, 10149 (2010)
23. D. Meierhofer, J. A. Mayr, U. Foetschl, A. Berger, K. Fink, N. Schmeller, G. W. Hacker, C. Hauser-Kronberger, B. Kofler and W. Sperl: Decrease of mitochondrial DNA content and energy metabolism in renal cell carcinoma. Carcinogenesis, 25(6), 1005-10 (2004) (Pubitemid 38886085)
24. P. A. Srere: Citrate synthase. Methods in enzymology, 133-5 (1969)
25. A. Berger, J. A. Mayr, D. Meierhofer, U. Fotschl, R. Bittner, H. Budka, C. Grethen, M. Huemer, B. Kofler and W. Sperl: Severe depletion of mitochondrial DNA in spinal muscular atrophy. Acta Neuropathol, 105(3), 245-51 (2003) (Pubitemid 36798816)
26. P. Rustin, D. Chretien, T. Bourgeron, B. Gerard, A. Rotig, J. M. Saudubray and A. Munnich: Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta, 228(1), 35-51 (1994) (Pubitemid 24231224)
27. B. Acham-Roschitz, B. Plecko, F. Lindbichler, R. Bittner, C. J. Mache, W. Sperl and J. A. Mayr: A novel mutation of the RRM2B gene in an infant with early fatal encephalomyopathy, central hypomyelination, and tubulopathy. Mol Genet Metab, 98(3), 300-4 (2009)
28. A. M. Balsaver, C. W. Gibley, Jr. and C. F. Tessmer: Ultrastructural studies in Wilms's tumor. Cancer, 22(2), 417-27 (1968)
29. J. B. Beckwith and N. F. Palmer: Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study. Cancer, 41(5), 1937-48 (1978) (Pubitemid 8335406)
30. N. E. Breslow, N. F. Palmer, L. R. Hill, J. Buring and G. J. D'Angio: Wilms' tumor: prognostic factors for patients without metastases at diagnosis: results of the National Wilms' Tumor Study. Cancer, 41(4), 1577-89 (1978) (Pubitemid 8333318)
31. A. Weirich, I. Leuschner, D. Harms, G. M. Vujanic, J. Troger, U. Abel, N. Graf, D. Schmidt, R. Ludwig and P. A. Voute: Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial a nd study SIOP-9/GPOH. Ann Oncol, 12(3), 311-9 (2001) (Pubitemid 32288685)
32. B. Ryu, J. Jones, M. A. Hollingsworth, R. H. Hruban and S. E. Kern: Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. Cancer Res, 61(5), 1833-8 (2001) (Pubitemid 32691994)
33. A. B. Seymour, R. H. Hruban, M. Redston, C. Caldas, S. M. Powell, K. W. Kinzler, C. J. Yeo and S. E. Kern: Allelotype of pancreatic adenocarcinoma. Cancer Res, 54(10), 2761-4 (1994) (Pubitemid 24173771)
34. H. Bonnefoi, C. Underhill, R. Iggo and D. Cameron: Predictive signatures for chemotherapy sensitivity in breast cancer: are they ready for use in the clinic? Eur J Cancer, 45(10), 1733-43 (2009)
35. B. Geoerger, B. Hero, D. Harms, J. Grebe, K. Scheidhauer and F. Berthold: Metabolic activity and clinical features of primary ganglioneuromas. Cancer, 91(10), 1905-13 (2001) (Pubitemid 32424118)
36. M. F. Horster, G. S. Braun and S. M. Huber: Embryonic renal epithelia: induction, nephrogenesis, and c ell differentiation. Physiol Rev, 79(4), 1157-91 (1999) (Pubitemid 29473314)
37. S. Hosono, X. Luo, D. P. Hyink, L. M. Schnapp, P. D. Wilson, C. R. Burrow, J. C. Reddy, G. F. Atweh and J. D. Licht: WT1 expression induces features of renal epithelial differentiation in mesenchymal fibroblasts. Oncogene, 1 8(2), 417-27 (1999) (Pubitemid 29060617)
38. S. Y. Plisov, S. V. Ivanov, K. Yoshino, L. F. Dove, T. M. Plisova, K. G. Higinbotham, I. Karavanova, M. Lerman and A. O. Perantoni: Mesenchymal- epithelial transition in the developing metanephric kidney: gene expression study by differential display. Genesis, 27(1), 22-31 (2000) (Pubitemid 30459208)
39. D. Baudry, M. O. Cabanis, C. Patte, J. M. Zucker, F. Pein, J. C. Fournet, S. Sarnacki, C. Junien and C. Jeanpierre: Cadherins in Wilms' tumor: E-cadherin expression despite absence of WT1. Anticancer Res, 23(1A), 475-8 (2003) (Pubitemid 36358555)
40. J. Alami, B. R. Williams and H. Yeger: Differential expression of E-cadherin and beta catenin in primary and metastatic Wilms's tumours. Mol Pathol, 56(4), 218-25 (2003) (Pubitemid 36981155)
41. C. H. Xie, A. Naito, T. Mizumachi, T. T. Evans, M. G. Douglas, C. A. Cooney, C. Y. Fan and M. Higuchi: Mitochondrial regulation of cancer associated nuclear DNA methylation. Biochem Biophys Res Commun, 364(3), 656- 61 (2007) (Pubitemid 350026513)
42. A. Naito, C. C. Cook, T. Mizumachi, M. Wang, C. H. Xie, T. T. Evans, T. Kelly and M. Higuchi: Progressive tumor features accompany epithelial- mesenchymal transition induced in mitochondrial DNA-depleted cells. Cancer Sci, 99(8), 1584-8 (2008)
43. V. Schumacher, S. Schuhen, S. Sonner, A. Weirich, I. Leuschner, D. Harms, J. Licht, S. Roberts and B. Royer- Pokora: Two molecular subgroups of Wilms' tumors with or without WT1 mutations. Clin Cancer Res, 9(6), 2005-14 (2003) (Pubitemid 36687619)
44. M. Little and C. Wells: A clinical overview of WT1 gene mutations. Hum Mutat, 9(3), 209-25 (1997) (Pubitemid 27138814)
45. J. Q. Kwong, M. S. Henning, A. A. Starkov and G. Manfredi: The mitochondrial respiratory chain is a m odulator of apoptosis. J Cell Biol, 179(6), 1163-77 (2007) (Pubitemid 350277736)
46. W. Ma, H. J. Sung, J. Y. Park, S. Matoba and P. M. Hwang: A pivotal role for p53: balancing aerobic respiration and glycolysis. J Bioenerg Biomembr, 39(3), 243-6 (2007) (Pubitemid 47619376)
47. N. Bardeesy, D. Falkoff, M. J. Petruzzi, N. Nowak, B. Zabel, M. Adam, M. C. Aguiar, P. Grundy, T. Shows and J. Pelletier: Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations. Nat Genet, 7(1), 91-7 (1994)
48. C. Lahoti, P. Thorner, D. Malkin and H. Yeger: Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome. Am J Pathol, 148(5), 1577-89 (1996) (Pubitemid 26135898)
49. D. Govender, P. Harilal, G. P. Hadley and R. Chetty: p53 protein expression in nephroblastomas: a predictor of poor prognosis. Br J Cancer, 77(2), 314-8 (1998) (Pubitemid 28029549)